Consultation open for inflammatory arthritis guideline

Version 3.0 of An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis is open for public consultation until 30th April 2023. Released by the Australia and New Zealand Musculoskeletal Clinical Trials Network, the Australian Rheumatology Association and Cochrane Musculoskeletal, topics covered in the guideline include choice of disease-modifying antirheumatic drug, combination therapy, down-titration of treatment and managing other medications such as opioids. Make a submission and access the guideline at: